Bloomberg Technology
Why Humacyte Is Going Public Via SPAC
Feb.17 — Dr. Laura Niklason, chief executive officer and founder of Humacyte, discusses the biotech company’s decision to go public through a merger with Alpha Healthcare Acquisition Corp., a special purpose acquisition company (SPAC). She speaks on “Bloomberg Markets: The Close.”
Samurai Western
February 17, 2021 at 8:37 pm
Old news 🗞
Charles Philip
February 17, 2021 at 8:38 pm
Nice video!! Very engaging from beginning to end. Nevertheless, businesses and investment are the easiest way to make money irrespective of which party makes it to the oval office.
Thompson Bruce
February 17, 2021 at 9:34 pm
+1-5-1-3-4-3-4-4-5-0-8
Jessica Susan
February 17, 2021 at 9:35 pm
His availability is on WhatsApp⬆️
Patricia Mary
February 17, 2021 at 9:36 pm
Thanks , placing my trade with expert Williams Smith ASAP
Olivia Ava
February 17, 2021 at 9:38 pm
My first investment with Mr Williams Smith gave me the assurance that has made me invest without the fear of losing, I got four of my friends involved with him already
Isabella Sophia
February 17, 2021 at 9:40 pm
I’m from the UK 🇬🇧 I and my colleagues gave him a try and it has been good returns of our investment, Thanks Mr Williams Smith🇱🇷
Clarence Boddicker
February 17, 2021 at 8:39 pm
If they can pull this off…. it will go to the moon and beyond
kelcy assh
February 17, 2021 at 9:14 pm
0:53
von.in.net
Swartz
February 17, 2021 at 9:53 pm
Great CEO